Autoinjector

DEVICE7 trials

Sponsors

Hoffmann-La Roche, Momenta Pharmaceuticals, Inc., Samsung Bioepis Co., Ltd., AbbVie, AstraZeneca

Conditions

Allergic ReactionBleedingHealthy Participants StudyHepatitis C, ChronicOverdose AntidotePsoriasisRheumatoid ArthritisThyroid Eye Disease

Phase 1

A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C

CompletedNCT01087944

Hoffmann-La RocheHepatitis C, Chronic

Start: 2010-03-31End: 2010-06-30Updated: 2016-02-09

Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in Anifrolumab

CompletedNCT05339100

AstraZenecaHealthy Participants Study

Start: 2022-03-22End: 2023-04-13Updated: 2023-05-11

Phase 2

An Multicentre Clinical Study to Evaluate the Usability and Safety of the Autoinjector and Pre-filled Syringe of SB4 in Subjects With Rheumatoid Arthritis

CompletedNCT03193957

Samsung Bioepis Co., Ltd.Rheumatoid Arthritis

Start: 2017-05-15End: 2017-09-25Updated: 2017-10-13

Phase 3

Usability of an AI for M923 in Subjects With Moderate to Severe RA

CompletedNCT02722044

Momenta Pharmaceuticals, Inc.Rheumatoid Arthritis

Start: 2016-04-30End: 2017-02-21Updated: 2018-05-16

A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis

CompletedNCT03875508

AbbViePsoriasis

Start: 2019-06-04End: 2020-08-25Updated: 2021-05-11

A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

Active, not recruitingNCT07155668

Viridian Therapeutics, Inc.Thyroid Eye Disease

Start: 2025-07-01End: 2026-11-30Updated: 2026-01-14

Unknown Phase

Assessment of Injectable Medication Platforms

Canadian Forces Health Services Centre OttawaAllergic Reaction, Bleeding, Overdose Antidote

Start: 2022-04-30End: 2025-01-01Target: 30Updated: 2023-02-08

Related Papers

Usability of Prefilled Syringe and Autoinjector for SB4 (An Etanercept Biosimilar) in Patients with Rheumatoid Arthritis.

2019-08-0111 citations